Eupraxia Pharmaceuticals press release ( EPRX ): The Company incurred a net loss of $12.7 million for the three months ended March 31, 2026, versus a net loss of $6.8 million for the three months ended March 31, 2025. The increase in net loss was primarily due to an increase in research and development costs as a result of doubling the size of the RESOLVE Part 2 trial and general and administrativ...
Eupraxia Pharmaceuticals press release ( EPRX ): The Company incurred a net loss of $12.7 million for the three months ended March 31, 2026, versus a net loss of $6.8 million for the three months ended March 31, 2025. The increase in net loss was primarily due to an increase in research and development costs as a result of doubling the size of the RESOLVE Part 2 trial and general and administrative costs, partially offset by an increase in other income. The Company had cash and cash equivalents of $58.5 million and short-term investments of $80.4 million as of March 31, 2026, up from a cash balance of $80.6 million at the end of the fourth quarter of 2025. The Company anticipates that existing cash reserves, and proceeds from the anticipated future exercise of in-the-money warrants, will be sufficient to fund the Company into the second half of 2028. As of March 31, 2026, the Company had 61,808,630 common shares and 8,355,638 preferred shares outstanding. More on Eupraxia Pharmaceuticals Eupraxia Pharmaceuticals reports Q4 results Eupraxia Pharmaceuticals files for proposed public share offering Historical earnings data for Eupraxia Pharmaceuticals Financial information for Eupraxia Pharmaceuticals
Expectations are running high for the US-China summit in Beijing, but Trump’s main goal should be to not make things worse, the Editorial Board writes. (Source: Bloomberg)
Expectations are running high for the US-China summit in Beijing, but Trump’s main goal should be to not make things worse, the Editorial Board writes. (Source: Bloomberg)
The total pay package for Nvidia Corp. Chief Executive Officer Jensen Huang decreased 27% to $36.3 million in fiscal 2026 after the value of his stock awards declined. Equity awards — the biggest component in Huang’s compensation — slipped 36% to $24.8 million in the fiscal year that ended Jan. 25, according to a regulatory filing Tuesday. In 2025, he received $38.8 million in stock awards, bringi...
The total pay package for Nvidia Corp. Chief Executive Officer Jensen Huang decreased 27% to $36.3 million in fiscal 2026 after the value of his stock awards declined. Equity awards — the biggest component in Huang’s compensation — slipped 36% to $24.8 million in the fiscal year that ended Jan. 25, according to a regulatory filing Tuesday. In 2025, he received $38.8 million in stock awards, bringing his total to $49.9 million. Though Nvidia remains the world’s most valuable company, the explosive gains in its stock have slowed in the past year. After tripling in 2023 and more than doubling in 2024, they rose 39% last year. The stock is up 18% so far in 2026, putting it on one of the slowest paces among major chip companies. Huang’s salary was little changed at $1.5 million in fiscal 2026, while his nonequity incentive plan compensation remained steady at $6 million.
BridgeBio Oncology Therapeutics, Inc. press release ( BBOT ): Q1 GAAP EPS of -$526.11. Cash Position: As of March 31, 2026, BBOT had cash, cash equivalents and marketable securities totaling $388.9 million, which is expected to provide cash runway into 2028. More on BridgeBio Oncology Therapeutics, Inc. BridgeBio Oncology Therapeutics: Poised To Bank On The KRAS Revolution BridgeBio Oncology rises...
BridgeBio Oncology Therapeutics, Inc. press release ( BBOT ): Q1 GAAP EPS of -$526.11. Cash Position: As of March 31, 2026, BBOT had cash, cash equivalents and marketable securities totaling $388.9 million, which is expected to provide cash runway into 2028. More on BridgeBio Oncology Therapeutics, Inc. BridgeBio Oncology Therapeutics: Poised To Bank On The KRAS Revolution BridgeBio Oncology rises on Fast Track status for pancreatic cancer asset BridgeBio Oncology Therapeutics, Inc. GAAP EPS of -$0.49 Seeking Alpha’s Quant Rating on BridgeBio Oncology Therapeutics, Inc. Historical earnings data for BridgeBio Oncology Therapeutics, Inc.
Lineage Cell (LCTX) delivered earnings and revenue surprises of -50.00% and -46.53%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Lineage Cell (LCTX) delivered earnings and revenue surprises of -50.00% and -46.53%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
With a 5-year average dividend growth rate of 12.60%, Broadcom Inc. (NASDAQ:AVGO) is included among the 14 Best Dividend Stocks to Buy for Steady Growth. On May 12, Citi analyst Atif Malik raised the firm’s price target on Broadcom Inc. (NASDAQ:AVGO) to $500 from $475 and maintained a Buy rating on the shares as part of an […]
With a 5-year average dividend growth rate of 12.60%, Broadcom Inc. (NASDAQ:AVGO) is included among the 14 Best Dividend Stocks to Buy for Steady Growth. On May 12, Citi analyst Atif Malik raised the firm’s price target on Broadcom Inc. (NASDAQ:AVGO) to $500 from $475 and maintained a Buy rating on the shares as part of an […]
Meren Energy press release ( MRNFF ): Q1 GAAP EPS of -$0.06. Strong liquidity position with cash of $161.6 million, net debt of $208.4 million, Net Debt/EBITDAX of 0.5x, together with $204.2 million of available RBL headroom. 2026 Management Guidance and Actuals The Company's full-year 2026 Management Guidance is unchanged and is copied here for completeness. The Company's full-year 2026 productio...
Meren Energy press release ( MRNFF ): Q1 GAAP EPS of -$0.06. Strong liquidity position with cash of $161.6 million, net debt of $208.4 million, Net Debt/EBITDAX of 0.5x, together with $204.2 million of available RBL headroom. 2026 Management Guidance and Actuals The Company's full-year 2026 Management Guidance is unchanged and is copied here for completeness. The Company's full-year 2026 production will be generated solely by its deepwater Nigerian assets. The 2026 Management Guidance includes W.I. production guidance range of 23.0 – 28.0 kboepd and entitlement production range of 28.0 – 33.0 kboepd with approximately 68% expected to be light and medium crude oil and 32% conventional natural gas on a W.I. basis and 73% and 27% respectively on an entitlement basis. The table below summarizes the Company's full-year 2026 Management Guidance. These estimates are based on a 2026 average Brent price of $63.0/bbl, based on 8 cargo liftings. 2026 Guidance Q1 2026 Actuals WI production (kboepd) (1) 23.0 – 28.0 28.4 Entitlement production (kboepd) (2) 28.0 – 33.0 31.0 EBITDAX ($ million) (3) 270.0 – 360.0 100.2 Cash flow from operations ($ million) (3) 185.0 – 255.0 79.0 Capital investments ($ million) 100.0 – 140.0 8.9 Click to enlarge More on Meren Energy Inc. Meren Energy - Higher Prices Come At A Critical Point Meren Energy: The Drilling Campaign Will Resume As This Company Moves Forward Quickly Meren Energy Inc. 2025 Q4 - Results - Earnings Call Presentation Historical earnings data for Meren Energy Inc. Dividend scorecard for Meren Energy Inc.
(RTTNews) - Alphabet Inc.'s Google (GOOG)is currently in talks with SpaceX and other launch providers for an exciting project called Project Suncatcher. The goal is to deploy solar-powered data centers in orbit.
(RTTNews) - Alphabet Inc.'s Google (GOOG)is currently in talks with SpaceX and other launch providers for an exciting project called Project Suncatcher. The goal is to deploy solar-powered data centers in orbit.
Altius Minerals press release ( ATUSF ): Q1 Non-GAAP EPS of C$0.11. Revenue of C$26.77M (+78.9% Y/Y). More on Altius Minerals Corporation Historical earnings data for Altius Minerals Corporation Dividend scorecard for Altius Minerals Corporation Financial information for Altius Minerals Corporation
Altius Minerals press release ( ATUSF ): Q1 Non-GAAP EPS of C$0.11. Revenue of C$26.77M (+78.9% Y/Y). More on Altius Minerals Corporation Historical earnings data for Altius Minerals Corporation Dividend scorecard for Altius Minerals Corporation Financial information for Altius Minerals Corporation
Anthropic PBC is in early talks with investors to raise at least $30 billion in fresh financing, according to people familiar with the matter, setting the stage for what could be its largest funding round yet. The Claude maker is in discussions to raise the new capital at a valuation of more than $900 billion, not including the investment, said the people, who spoke on condition of anonymity as th...
Anthropic PBC is in early talks with investors to raise at least $30 billion in fresh financing, according to people familiar with the matter, setting the stage for what could be its largest funding round yet. The Claude maker is in discussions to raise the new capital at a valuation of more than $900 billion, not including the investment, said the people, who spoke on condition of anonymity as the information is private. The round is expected to close as soon as the end of this month, one person said. The deal is not finalized and no term sheet has been signed. The new discussions, which have not been reported, coincide with a push by Anthropic to ramp up fundraising amid the breakout success of its AI software. Anthropic, which Bloomberg has reported is considering an initial public offering as soon as October, needs to make deals to pay for enough computing infrastructure to meet growing demand for its products. Anthropic declined to comment. Anthropic had previously been weighing whether to pursue a funding round at a more than $900 billion valuation after receiving several inbound proposals from investors in recent weeks, Bloomberg News has reported . The company has since held discussions with existing backers about participating in the new round, the people said. Anthropic recently secured two major financing deals with Big Tech firms, though it’s unclear whether those companies will be part of the upcoming funding round. Google committed to invest $10 billion in Anthropic at a $350 billion valuation, the same amount it was valued at in a $30 billion funding round in February. The Alphabet Inc. -owned company plans to invest up to another $30 billion in Anthropic if the startup hits certain performance targets. Amazon.com Inc. is also investing $5 billion in Anthropic at a $350 billion valuation, with plans to inject $20 billion more over time. Founded in 2021 by a group of former OpenAI employees, Anthropic has since emerged as a leader in the AI sector. Ant...
(Bloomberg) -- Anthropic PBC is in early talks with investors to raise at least $30 billion in fresh financing, according to people familiar with the matter, setting the stage for what could be its largest funding round yet.Most Read from BloombergAmbani’s Cola War With Coke, Pepsi Spurs Fridge Bonanza in IndiaInside a Year of Chaos and Conflict at Kevin Hart’s Media CompanyIran Makes New Offer on...
(Bloomberg) -- Anthropic PBC is in early talks with investors to raise at least $30 billion in fresh financing, according to people familiar with the matter, setting the stage for what could be its largest funding round yet.Most Read from BloombergAmbani’s Cola War With Coke, Pepsi Spurs Fridge Bonanza in IndiaInside a Year of Chaos and Conflict at Kevin Hart’s Media CompanyIran Makes New Offer on Uranium in Response to US, WSJ SaysMamdani Scraps Property Tax Hike, Counts Second-Home RevenueThe
Wesdome Gold Mines press release ( WDOFF ): Q1 GAAP EPS of C$0.79. Revenue of C$299.79M (+59.8% Y/Y). More on Wesdome Gold Mines Ltd. Wesdome Gold Mines: High-Grade Gold Production At A Reasonable Price Wesdome Gold Mines Ltd. (WDO:CA) Q4 2025 Earnings Call Transcript Wesdome Gold Mines launches share buybacks under normal course issuer bid Wesdome Gold Mines Non-GAAP EPS of $0.78, revenue of $287...
Wesdome Gold Mines press release ( WDOFF ): Q1 GAAP EPS of C$0.79. Revenue of C$299.79M (+59.8% Y/Y). More on Wesdome Gold Mines Ltd. Wesdome Gold Mines: High-Grade Gold Production At A Reasonable Price Wesdome Gold Mines Ltd. (WDO:CA) Q4 2025 Earnings Call Transcript Wesdome Gold Mines launches share buybacks under normal course issuer bid Wesdome Gold Mines Non-GAAP EPS of $0.78, revenue of $287.88M; expects to produce 180,000 to 205,000 ounces in FY26 Historical earnings data for Wesdome Gold Mines Ltd.
Helios Gets Support Along 50-Day Line Ahead Of November 8 Earnings ReportHelios Technologies (NYSE:HLIO) reported a stronger-than-expected first quarter for fiscal 2026, with management pointing to broad-based sales growth, margin expansion and record first-quarter cash generatio
Helios Gets Support Along 50-Day Line Ahead Of November 8 Earnings ReportHelios Technologies (NYSE:HLIO) reported a stronger-than-expected first quarter for fiscal 2026, with management pointing to broad-based sales growth, margin expansion and record first-quarter cash generatio
Constellation Software press release ( CNSWF ): Q1 GAAP EPS of $17.32. Revenue of $3.18B (+20.0% Y/Y) beats by $40M . Cash flows from operations were $897 million, an increase of 9%, or $70 million, compared to $827 million for the comparable period in 2025. Free cash flow available to shareholders were $733 million, an increase of 44%, or $223 million, compared to $510 million for the comparable ...
Constellation Software press release ( CNSWF ): Q1 GAAP EPS of $17.32. Revenue of $3.18B (+20.0% Y/Y) beats by $40M . Cash flows from operations were $897 million, an increase of 9%, or $70 million, compared to $827 million for the comparable period in 2025. Free cash flow available to shareholders were $733 million, an increase of 44%, or $223 million, compared to $510 million for the comparable period in 2025. More on Constellation Software Constellation Software: A Business Built To Compound Constellation Software: My Reasons For Believing Business Will Prove Durable Constellation Software: Not Threatened By AI Constellation Software’s Vela to acquire majority interest in Derbysoft Holdings Constellation Software GAAP EPS of $5.19, revenue of $3.18B beats by $30M